Follow TV Tropes

Following

History Headscratchers / MissionImpossibleII

Go To

OR

Added: 3041

Removed: 27

Is there an issue? Send a MessageReason:
None


!!''Mission: Impossible 2''



** Especially with Nyah loose, if she started an epidemic, they'd need to have massive production by the next day. (Ambrose says 3 million in Sydney, 17 million in Australia within days.)

to:

** Especially with Nyah loose, if she started an epidemic, they'd need to have massive production by the next day. (Ambrose says 3 million in Sydney, 17 million in Australia within days.)
* The plan for the disease and its cure developed over the movie.
** [=McCloy's=] plan was originally as follows: he had Nakovitch develop a super flu, Chimera, to drive demand so that he can sell its cure, Bellerophon. He tested it out on Bruny island, accidentally killing five hundred people.
** Nakovitch originally thought he was working on a universal flu cure (in developing Chimera), but realized [=McCloy's=] plan and tried to foil it by taking ''all'' the Bellerophon with him, and injecting himself with Chimera, which can then be drawn out at the CDC in Atlanta.
*** At this point [=McCloy=] has Chimera but no Bellerophon, and Nakovitch has both Chimera and Bellerophon.
*** Presumably he takes ''all'' the Bellerophon so that [=McCloy=] can no longer release Chimera (since he has no cure to sell).
*** He doesn't destroy the Chimera, as that would be too visible (it's alarmed) ... though presumably the Bellerophon would also be alarmed?
*** It would obviously be safer to bring infected blood (as Ambrose has later on), and he's already transporting suspicious vials of Bellerophon. Perhaps there's no time to culture it before leaving, though he could inject himself before the flight, then draw his blood and cure himself at a lay-over.
** Ambrose steals the Bellerophon but kills Nakovitch, so he doesn't have Chimera. At this point Ambrose has ''all'' the Bellerophon, and [=McCloy=] has ''all'' the Chimera.
** The cure is only valuable in combination with the disease (Chimera) ("two halves of the same dollar bill"), so [=McCloy=] makes the top offer of £37 million (which is absurdly low for an effective drug, but Ambrose has no other buyers).
** Rather than accept this, Ambrose realizes that he can steal the virus himself, so he has both the virus and the cure, and can sell it to anyone, negotiating a much higher price.
** Ethan's plan is to destroy all the Chimera, so there's no more threat, and Ambrose's cure is no longer valuable.
** Ethan almost succeeds, destroying all the virus except one injection gun.
** ... which Nyah then injects into herself, and is recaptured by Ambrose.
** Ambrose now has all the Bellerophon (in vials) and all the Chimera (in Nyah).
** Ambrose draws blood from Nyah, so he has a supply of Chimera, and lets Nyah loose to start the epidemic anyways.
** Swanbeck wants both Bellerophon and Chimera.
** Ambrose then negotiates with [=McCloy=] to instead get a majority stake in Biocyte, expected to be worth almost 10 billion ... pounds (?) (options for 48 million shares, at over 200 pounds (?) each, is 9.6 billion).
*** He needs Biocyte to produce and distribute Bellerophon: any large drug company would do, but [=McCloy=] is already a known evil and has the facilities.
** Ethan then recovers all the Bellerophon and all Nyah's Chimera-filled blood (in the canister), and then Nyah herself ... and cures Nyah and burns the canister, destroying both the Chimera and the Bellerophon, so none of either are left. (Disobeying Swanbeck; Ethan states Bellerophon was only useful against Chimera.
)
Is there an issue? Send a MessageReason:
None

Added DiffLines:

*** In the series it was at least ''implied'' that they were part of the U.S. government, since their leader is called "The Secretary" (a title used for the heads of U.S. government departments) and they seemed to do a lot of things to advance U.S. interests. But yeah, you could still interpret it as a private organization.
Is there an issue? Send a MessageReason:
explain low price


* The initial bids for Bellerophon are ludicrously low; £37 million is about the cost of developing a single vaccine (before trials), much less a super cure. Even without Chimera, an anti-flu drug would be worth billions.
** This is acknowledged later, when Ambrose expects to earn billions (in stock value).

to:

* The initial bids for Bellerophon are ludicrously low; £37 million is about the cost of developing a single vaccine (before trials), much less a super cure. Even without Chimera, an anti-flu drug would be worth billions.
cure.
** This is acknowledged later, because Ambrose can't monetize it otherwise, so [=McCloy=] is the only effective partner: it's only good against Chimera, so he has "half of a dollar bill", and when Ambrose also gets Chimera, he expects to earn billions (in stock value).

Top